FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to the use of 2- (R) - (4-fluoro-2-methyl-phenyl) -4- (S) - ((8аS) -6-oxo-hexahydro-pyrrolo [1,2-a] pyrazine -2-yl) -piperidine-1-carboxylic acid [1- (R) - (3,5-bis-trifluoromethyl-phenyl) -ethyl] -methylamide (orvepitant) or a pharmaceutically acceptable salt thereof to prepare a drug for chronic cough treatment. Also proposed is the use of a pharmaceutical composition and a method for chronic cough treatment.
EFFECT: new application of orvepitant or its pharmacologically acceptable salt and pharmaceutical composition containing it is proposed for preparation of a drug for chronic cough treatment.
21 cl, 2 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | 2014 |
|
RU2674983C1 |
| NEW COMPOUNDS - NEUROKININ 1 RECEPTOR ANTAGONIZER | 2013 |
|
RU2631319C2 |
| IMIDAZO[1,2-A]PYRAZIN-1-YL-BENZAMIDES FOR TREATING SPINAL MUSCULAR ATROPHY | 2015 |
|
RU2725979C2 |
| SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR TREATING VESTIBULAR DISORDERS | 2009 |
|
RU2589846C2 |
| USE OF SIGMA LIGANDS FROM PAIN IN BONE CANCER | 2011 |
|
RU2585095C2 |
| 2-PYRAZINONE DERIVATIVES FOR TREATING DISEASES OR CONDITIONS WHERE INHIBITING NEUTROPHIL ELASTASE ACTIVITY IS USEFUL | 2007 |
|
RU2448098C2 |
| PYPERIDINE DERIVATIVES AND METHOD OF THEIR OBTAINING, APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON THEM AND METHOD OF TREATMENT | 2003 |
|
RU2336276C2 |
| APPLICATION OF RECEPTOR NK-1 ANTAGONISTS FOR TREATING CRANIOCEREBRAL AND SPINAL TRAUMAS OR NERVOUS TISSUE LESION | 2002 |
|
RU2304435C2 |
| OXAZINMONOACYLGLYCERIN LIPASE (MAGL) INHIBITORS | 2019 |
|
RU2794334C2 |
| SIGMA-LIGANDS FOR APPLICATION IN PREVENTION AND/OR TREATMENT OF POSTOPERATIVE PAIN | 2011 |
|
RU2569055C2 |
